Clinical trial
LOSS- Louisiana Obese Subjects Study
NCT00115063 · Pennington Biomedical Research Center, Other · Terminated
Key facts
| NCT number | NCT00115063 |
|---|---|
| Title | LOSS- Louisiana Obese Subjects Study |
| Official title | Loss - Louisiana Obese Subjects Study |
| Acronym | LOSS |
| Lead sponsor | Pennington Biomedical Research Center, Other |
| Collaborators | Louisiana Office of Group Benefits |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Obesity |
| Intervention type | Behavioral, Drug, Other |
| Interventions | group sessions, sibutramine, orlistat, diethylpropion, Low Calorie Diet, Health One, Intensive Medical Combination Therapy for Obesity, Control Condition |
| Enrollment | 390 |
| Start date | Jul 1, 2005 |
| Primary completion | Dec 1, 2007 |
| Completion | Jan 1, 2008 |
| First posted | Jun 21, 2005 |
| Last update posted | Feb 22, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: